Key Dates

Related Announcements

RFA-HL-19-015 Physician-Scientist (PS) Research Award for Early Stage Investigators (ESIs) (R01 - Clinical Trial Optional)

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this notice is to inform potential applicants that a second application due date for all types of non-AIDS applications of July 10, 2020 has been added for the final Advisory Council Review (January 2021) for RFA-HL-19-015 Physician-Scientist (PS) Research Award for Early Stage Investigators (ESIs) (R01 - Clinical Trial Optional) . Scientific Merit Review, Advisory Council Review, Earliest Start Date and Expiration Date remain unchanged.

The following section of RFA-HL-19-015 has been updated to reflect the additional application due date for the January 2021 Advisory Council Review:

Part 1. Overview Information

Key Dates

Currently reads:

Application Due Date(s)

June 4, 2018, June 4, 2019, June 4, 2020, by 5:00 PM local time of applicant organization.

Modified to read:

Application Due Date(s)

June 4, 2018, June 4, 2019, June 4, 2020, and July 10, 2020 by 5:00 PM local time of applicant organization.

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Lindsay Garvin, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-7911
Email: [email protected]